FTC's First Product Hopping Complaint Targets Safety Claims For Suboxone Film Formulation

Commission files complaint as it reaches $50m settlement with Reckitt Benckiser.

Hare running in a meadow - Image
US Federal Trade Commission files its first product-hopping complaint

The US Federal Trade Commission's antitrust complaint against Reckitt Benckiser Group PLC for its promotion of Suboxone film (buprenorphine/naloxone) as less susceptible to accidental pediatric exposure than the tablet formulation shows the kind of product hopping behavior the agency may pursue in the future.

The agency has expressed interest in going after drug makers for so-called product hopping, in which a drug manufacturer tries...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet